WS15.06 Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycinboosted gETI as modulator-sparing strategies to reduce cost.

Subjects

Subjects :

*SOUTH Africans
*COST

Details

Language :

English

ISSN :

15691993

Volume :

23

Database :

Academic Search Index

Journal :

Journal of Cystic Fibrosis

Publication Type :

Academic Journal

Accession number :

177679429

Full Text :

https://doi.org/10.1016/S1569-1993(24)00198-X